Voyager Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Voyager Therapeutics

13/05/2024 22:22

* Voyager Therapeutics Inc  VYGR.OQ  reported a quarterly
adjusted
loss of 20 cents​​ per share for the quarter ended in March,
lower than the same quarter last year, when the company reported
EPS of $2.94.  The mean expectation of nine analysts for the
quarter was for a loss of 44 cents per share. Wall Street
expected results to range from -52 cents to -31 cents per share.
    * Revenue fell 87% to $19.52 million from a year ago;
analysts
expected $9.42 million. 
    * Voyager Therapeutics Inc's reported EPS for the quarter
was a
loss of 20 cents​.
    * The company reported a quarterly loss of $11.33 million.
    * Voyager Therapeutics Inc shares had fallen by 9.3% this
quarter and held steady so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 77.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Voyager
Therapeutics Inc is $18.00 
This summary was machine generated from LSEG data May 13 at
09:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.44          -0.20          Beat
 Dec. 31 2023      -0.29          1.25           Beat
 Sep. 30 2023      -0.58          -0.59          Missed
 Jun. 30 2023      -0.57          -0.51          Beat